Harbin Gloria Pharmaceuticals (002437) — Cash Flow-to-Debt Ratio
Harbin Gloria Pharmaceuticals (002437) has a Cash Flow-to-Debt Ratio of 0.21x as of September 2025, meaning its operating cash flow of CN¥182.89 Million could theoretically repay 0% of its total liabilities (CN¥852.18 Million) in one year. Explore 002437 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Harbin Gloria Pharmaceuticals Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Harbin Gloria Pharmaceuticals across 19 annual periods. Also explore how large is Harbin Gloria Pharmaceuticals's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year debt coverage analysis for Harbin Gloria Pharmaceuticals. For market capitalisation and broader financial context, see 002437 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥273.36 Million | CN¥825.00 Million | ▼ -31.3% |
| 2024 | 0.48x | CN¥410.94 Million | CN¥852.26 Million | ▲ +153.6% |
| 2023 | 0.19x | CN¥274.18 Million | CN¥1.44 Billion | ▲ +72.3% |
| 2022 | 0.11x | CN¥261.62 Million | CN¥2.37 Billion | ▲ +9.3% |
| 2021 | 0.10x | CN¥274.18 Million | CN¥2.72 Billion | ▲ +1943.0% |
| 2020 | 0.00x | CN¥12.76 Million | CN¥2.58 Billion | ▼ -96.1% |
| 2019 | 0.13x | CN¥610.37 Million | CN¥4.82 Billion | ▼ -44.6% |
| 2018 | 0.23x | CN¥1.16 Billion | CN¥5.08 Billion | ▲ +68.9% |
| 2017 | 0.14x | CN¥651.80 Million | CN¥4.81 Billion | ▼ -39.9% |
| 2016 | 0.23x | CN¥1.04 Billion | CN¥4.62 Billion | ▲ +55.4% |
| 2015 | 0.14x | CN¥702.05 Million | CN¥4.85 Billion | ▼ -60.9% |
| 2014 | 0.37x | CN¥674.04 Million | CN¥1.82 Billion | ▼ -62.0% |
| 2013 | 0.98x | CN¥453.02 Million | CN¥464.60 Million | ▼ -3.5% |
| 2012 | 1.01x | CN¥205.89 Million | CN¥203.79 Million | ▼ -9.7% |
| 2011 | 1.12x | CN¥128.61 Million | CN¥114.91 Million | ▼ -26.7% |
| 2010 | 1.53x | CN¥112.59 Million | CN¥73.73 Million | ▲ +38.5% |
| 2009 | 1.10x | CN¥170.82 Million | CN¥154.95 Million | ▲ +62.4% |
| 2008 | 0.68x | CN¥57.81 Million | CN¥85.17 Million | ▲ +0.2% |
| 2007 | 0.68x | CN¥52.26 Million | CN¥77.15 Million | — |